National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Flu
 Understanding Flu
 H1N1 Flu (Swine)
 Research
  Recent Findings
  Basic Research
  Diagnostic Progress
  Advances in Treatment
  Pandemic
  Vaccine Research
  How and Where NIAID Research Happens
  Service and Resources for Researchers
  Clinical Studies
  Reports and Plans
  Funding Opportunities


Flu (Influenza)

Vaccinating Children to Produce "Community Immunity"

Can vaccinating a large percentage of its children protect a community from a possible flu epidemic?

Photo of Pedro Piedra, M.D.
Pedro Piedra, M.D.
That's a key question researchers from Baylor College of Medicine, Houston, are trying to answer through a large-scale vaccination effort in the towns of Temple and Belton, Texas (population 65,000-70,000). The NIAID-supported study is a continuation of an earlier clinical study. That study found that immunizing 20 to 25 percent of children in the two communities over a four-year period indirectly helped protect 8 to 18 percent of adults in the area from the flu.

This indirect effect, called herd or community immunity, results when a sufficient portion of a community has been immunized, so that even those who haven't been vaccinated escape infection because fewer people can transmit the virus. Children are often a source of the flu virus, passing it onto their friends, teachers, and families.

In the earlier study, researchers also found that the nasal spray flu vaccine in children 18 months to 18 years of age, the primary vaccination method, was safe and offered significant protection from the flu, with one dose frequently lasting through at least two flu seasons. Available commercially as FluMist, for healthy people ages 5 to 49 years, the nasal spray flu vaccine protects against three flu strains.

In the follow-up study, principal investigator Pedro Piedra, M.D., and his colleagues are expanding their reach. They will be attempting to double the number of children they vaccinate by developing a widespread school-based vaccination program. In doing so, they are hoping to prevent the spread of influenza among the younger population as well as adults. (In the follow-up study, only healthy children ages 5 to 18 can receive FluMist, due to FDA guidelines. Other age-eligible children will be offered a regular flu shot.)

The researchers also are hoping to answer the $100 million question: how many children need to be vaccinated to get 100 percent protection in a community?

Assisting in the study are health care professionals from Scott and White Clinic and Hospital, Houston.

Related Links

Non-government

back to top

Flu.gov

Community Immunity

Link to Community Immunity illustration Learn how immunizing a critical portion of a community protects most members of the community.

Volunteer for Clinical Studies Button

  • Complete list of  NIAID-funded clinical studies related to flu on ClinicalTrials.gov.
  • Studies at the NIH Clinical Center in Bethesda, MD
  •  

    Related Links

    View a list of links for more information about influenza.

    See Also

    Influenza News Releases 


    Flu.gov

    Community Immunity

    Link to Community Immunity illustration Learn how immunizing a critical portion of a community protects most members of the community.

    Volunteer for Clinical Studies Button

  • Complete list of  NIAID-funded clinical studies related to flu on ClinicalTrials.gov.
  • Studies at the NIH Clinical Center in Bethesda, MD
  •  

    Related Links

    View a list of links for more information about influenza.

    See Also

    Influenza News Releases